Alector Inc at Citi BioPharma Conference (Virtual)- Panel: What's Next for Neurodegenerative Diseases Transcript
So good morning, everybody, and thank you for attending Citi's 16th Annual Biopharma Conference. I'm Neena Bitritto-Garg, I'm one of the biotech analysts here at Citi, if you don't already know me.
For our next session, I'm really pleased to be joined this morning by the CEOs of 3 companies working in the neurodegenerative disease space, including Arnon Rosenthal, from Alector; Bruce Goldsmith from Passage Bio; and Gene Kinney from Prothena. So we're going to cover some emerging topics kind of on the outlook neurodegenerative disease, R&D at a high level and then some indication and company-specific questions as well.
And if anybody listening to the webcast has questions as we go through the discussion you can feel free to e-mail me directly or you can submit questions through the online portal and they'll come to me and I'll try and incorporate them as time permits. So I just want to start off by turning it over to all of you to kind of give some opening remarks. Maybe we can go
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
